Altre lingue Pfizer Limited

Azioni

PFIZER

INE182A01018

Tempo differito NSE India S.E. Altri mercati azionari 07:47:35 08/05/2024			Variaz. 5gg	Var. 1 gen.
4.275 ^INR	+0,30%		+0,07%	+0,26%

02/04	Pfizer Limited nomina Amit Agarwal come Amministratore a tempo pieno, designato come Direttore esecutivo Finanza	CI
28/03	La China's National Medical Products Administration accetta la richiesta di licenza biologica supplementare di Astellas e Pfizer per Enfortumab Vedotin con Keytruda (Pembrolizumab) per il trattamento di prima linea del tumore alla vescica avanzato	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Pfizer Limited Receives Order from Deputy Commissioner, Dehradun - Sector 8: Uttarakhand	25/04
Pfizer Limited Appoints Amit Agarwal as Chief Financial Officer	02/04
Pfizer Limited Appoints Amit Agarwal as Whole-Time Director, Designated as Executive Director Finance	02/04
China's National Medical Products Administration Accepts Astellas and Pfizer's Supplemental Biologics License Application for Enfortumab Vedotin with Keytruda (Pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer	28/03
Pfizer Limited Receives an Order from Joint Commissioner of State Tax Basis the GST Audit Conducted for Uttar Pradesh State for the Financial Year 2018-19	22/03
Pfizer Limited Receives an Order from Deputy Commissioner of State Tax Basis the GST Audit Conducted for the Financial Year 2018-19	19/03
Pfizer Limited Informs Satyen Amin, Lead - Market Access Tenders His Resignation from Employment, with Effect from March 31, 2024	09/02
Pfizer Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	09/02
Pfizer Ltd. Names CFO	22/01
Pfizer CFO Retires	01/12
Pfizer Limited Announces Retirement of Mr. Milind Patil as Chief Financial Officer	30/11
Pfizer Limited Appoints Ms. Aditi Mehta as Category Lead, Vaccines Effective December 1, 2023	16/11
Pfizer Limited Announces Resignation of Mr. Milind Patil as Director with Effect from Close of Business on November 13, 2023	13/11
Pfizer Sees Sharp Fall in Fiscal Q2 Net Profit	30/10/23
Pfizer Limited Announces Resignation of Samir Kazi as Director from the Board of Directors	28/10/23
Pfizer Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	28/10/23
Pfizer : Annual Return 2022 – 23	17/10/23
Pfizer Limited Appoints Chaitanya Nadkarni as India Digital Client Partner Lead	06/09/23
Pfizer Limited Approves A Final Dividend for the Financial Year Ended March 31, 2023	21/08/23
Pfizer Limited Announces Change in Management, Effective September 1, 2023	18/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Pfizer Limited

Azioni

PFIZER

INE182A01018

Altre lingue

Filtri